Literature DB >> 10083964

Aggressive pharmacologic treatment of pain.

M Pappagallo1.   

Abstract

In this article, the author outlines the pharmacology of nociception and discusses the two major classes of drugs used for pain control: opioids and nonopioid analgesics. In order to provide satisfactory pain relief and prevent the possible sequelae of untreated pain, physicians must possess both knowledge and expertise in the use of opioid and nonopioid analgesics. Opioid analgesics have been underused in the management of pain. Opioids have a higher analgesic potency and wider range of indications than any of the other currently available medications for pain control. The second class of drugs, the nonopioid analgesics and adjuvants, has recently expanded to include new and potentially beneficial medications. This article furthers the understanding on how to use analgesics for a prompt, safe, and effective pharmacologic treatment of acute and chronic pain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10083964     DOI: 10.1016/s0889-857x(05)70060-0

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  5 in total

Review 1.  Muscle pain due to injury.

Authors:  A H Wheeler; G W Aaron
Journal:  Curr Pain Headache Rep       Date:  2001-10

Review 2.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 3.  Myofascial pain disorders: theory to therapy.

Authors:  Anthony H Wheeler
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Identifying physician-recognized depression from administrative data: consequences for quality measurement.

Authors:  Claire M Spettell; Terry C Wall; Jeroan Allison; Jaimee Calhoun; Richard Kobylinski; Rachel Fargason; Catarina I Kiefe
Journal:  Health Serv Res       Date:  2003-08       Impact factor: 3.402

5.  Imaging-guided hyperstimulation analgesia in low back pain.

Authors:  Miguel Gorenberg; Kobi Schwartz
Journal:  J Pain Res       Date:  2013-06-25       Impact factor: 3.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.